Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.

× No keyword cloud information.

79 in total

Review 1. Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors: Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal: Physiol Rev Date: 2016-10 Impact factor: 37.312

2. Patient-centered Outcomes in Idiopathic Pulmonary Fibrosis Clinical Trials.

Authors: Anna J Podolanczuk; David J Lederer
Journal: Am J Respir Crit Care Med Date: 2017-09-15 Impact factor: 21.405

Review 3. Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis.

Authors: Gillian M Keating
Journal: Drugs Date: 2015-07 Impact factor: 9.546

Review 4. Matrix biomechanics and dynamics in pulmonary fibrosis.

Authors: Andrew J Haak; Qi Tan; Daniel J Tschumperlin
Journal: Matrix Biol Date: 2017-12-21 Impact factor: 11.583

Review 5. Resolution of organ fibrosis.

Authors: Joon-Il Jun; Lester F Lau
Journal: J Clin Invest Date: 2018-01-02 Impact factor: 14.808

Review 6. Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases.

Authors: Gauthami Pulivendala; Swarna Bale; Chandraiah Godugu
Journal: Drug Deliv Transl Res Date: 2020-04 Impact factor: 4.617

7. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.

Authors: Jamie L Todd; Megan L Neely; C A Finlen Copeland; Courtney W Frankel; John M Reynolds; Scott M Palmer
Journal: J Heart Lung Transplant Date: 2018-10-31 Impact factor: 10.247

8. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.

Authors: Brett Ley; Jeffrey Swigris; Bann-Mo Day; John L Stauffer; Karina Raimundo; Willis Chou; Harold R Collard
Journal: Am J Respir Crit Care Med Date: 2017-09-15 Impact factor: 21.405

Review 9. The next generation of therapeutics for chronic kidney disease.

Authors: Matthew D Breyer; Katalin Susztak
Journal: Nat Rev Drug Discov Date: 2016-05-27 Impact factor: 84.694

Review 10. TGF-β signaling in the kidney: profibrotic and protective effects.

Authors: Angara Sureshbabu; Saif A Muhsin; Mary E Choi
Journal: Am J Physiol Renal Physiol Date: 2016-01-06